Shattuck Labs, Inc.

STTK · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.6B · 40 employees
90
SEC Filings
$5.54
Close 2026-10-26
40
Employees

Business Summary

Shattuck Labs, Inc. is a clinical-stage biotechnology company developing first-in-class monoclonal and bispecific Death Receptor 3 (DR3) blocking antibodies for inflammatory and immune-mediated diseases. Its lead product candidate, SL-325, is a high-affinity DR3 blocking monoclonal antibody currently in a Phase 1 SAD/MAD clinical trial in healthy volunteers, with a Phase 2 trial in Crohn's Disease planned for Q3 2026. The company is also developing SL-425, a half-life extended version of SL-325, and multiple preclinical DR3-based bispecific antibodies targeting the DR3/TL1A axis alongside other validated immune targets.

Latest Stock Quote

STTK 2026-10-26 $5.54 O:$5.53 H:$5.69 L:$5.46 Vol:0.7M VWAP:$5.5603
origin leaf: null

Next Earnings

expected 2027-02-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001628280-26-014989EDGAR67K words
2025-03-272024-12-310001680367-25-000012EDGAR65K words
2024-02-292023-12-310001680367-24-000014EDGAR66K words
2023-02-232022-12-310001680367-23-000019EDGAR64K words
2022-03-152021-12-310001680367-22-000005EDGAR63K words
2021-03-162020-12-310001680367-21-000008EDGAR79K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-052026-09-300001628280-26-070618EDGAR20K words
2026-08-112026-06-300001628280-26-055483EDGAR19K words
2025-11-062025-09-300001680367-25-000057EDGAR22K words
2025-08-142025-06-300001680367-25-000046EDGAR21K words
2025-05-012025-03-310001680367-25-000034EDGAR18K words
2024-11-142024-09-300001680367-24-000053EDGAR34K words
2024-08-012024-06-300001680367-24-000040EDGAR19K words
2024-05-022024-03-310001680367-24-000025EDGAR17K words
2023-11-092023-09-300001680367-23-000062EDGAR19K words
2023-08-102023-06-300001680367-23-000050EDGAR17K words
2023-05-092023-03-310001680367-23-000035EDGAR16K words
2022-11-092022-09-300001680367-22-000034EDGAR20K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-050001628280-26-070613EDGAR3K words
2026-08-110001628280-26-055484EDGAR3K words
2026-03-050001628280-26-014987EDGAR3K words
2026-02-050001193125-26-039488EDGAR1K words
2026-01-220001193125-26-019682EDGAR28K words
2025-11-060001680367-25-000056EDGAR2K words
2025-08-260001193125-25-188078EDGAR1K words
2025-08-140001680367-25-000044EDGAR2K words
2025-08-050001193125-25-173010EDGAR1K words
2025-07-150001193125-25-159387EDGAR1K words

90 total filings indexed. 62 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

inflammatory-bowel-disease-(crohn's-disease,-ulcerative-colitis) hidradenitis-suppurativa psoriatic-arthritis rheumatoid-arthritis asthma multiple-sclerosis other-immune-mediated-and-inflammatory-diseases glp-toxicology-studies ind-enabling-studies non-human-primate-(nhp)-acute-toxicology

Company Identity

CIK0001680367
TickerSTTK
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.shattucklabs.com
Listed2020-10-09

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: fe0b85a7eaa76dcaf809f970dc66b5d87b8aa1a54e07831b6101115318707021
parent: f9e52050f2409c31c6e14be3b069812fc3a82d5bb9be0a57e1163146f7e632df
content hash: 718feb290f55b4c239a1664df3c0c42aab6767165aadf161d418c46d3e06954e
signed: 2026-11-16T19:04:58.360Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up STTK using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on STTK, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/STTK (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.